NASDAQ:CCCC

C4 Therapeutics News Headlines

$32.66
-1.06 (-3.14 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$32.00
Now: $32.66
$33.78
50-Day Range
$32.90
MA: $40.29
$44.64
52-Week Range
$22.40
Now: $32.66
$48.97
Volume654,544 shs
Average Volume261,495 shs
Market Capitalization$1.41 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

C4 Therapeutics (NASDAQ CCCC) News Headlines Today

SourceHeadline
Should You Take Comfort From Insider Transactions At C4 Therapeutics, Inc. (NASDAQ:CCCC)?Should You Take Comfort From Insider Transactions At C4 Therapeutics, Inc. (NASDAQ:CCCC)?
nasdaq.com - April 10 at 1:57 PM
Insider Selling: C4 Therapeutics, Inc. (NASDAQ:CCCC) Insider Sells 15,000 Shares of StockInsider Selling: C4 Therapeutics, Inc. (NASDAQ:CCCC) Insider Sells 15,000 Shares of Stock
americanbankingnews.com - April 6 at 4:48 PM
C4 Therapeutics (NASDAQ:CCCC)  Shares Down 3.8% C4 Therapeutics (NASDAQ:CCCC) Shares Down 3.8%
americanbankingnews.com - April 5 at 12:44 PM
C4 Therapeutics (NASDAQ:CCCC) Shares Up 11.9%C4 Therapeutics (NASDAQ:CCCC) Shares Up 11.9%
americanbankingnews.com - March 31 at 1:26 PM
C4 Therapeutics (NASDAQ:CCCC) Now Covered by Analysts at BMO Capital MarketsC4 Therapeutics (NASDAQ:CCCC) Now Covered by Analysts at BMO Capital Markets
americanbankingnews.com - March 31 at 8:04 AM
BMO Capital Markets Begins Coverage on C4 Therapeutics (NASDAQ:CCCC)BMO Capital Markets Begins Coverage on C4 Therapeutics (NASDAQ:CCCC)
americanbankingnews.com - March 31 at 8:04 AM
C4 Therapeutics Enters Oversold TerritoryC4 Therapeutics Enters Oversold Territory
nasdaq.com - March 29 at 7:48 PM
C4 Therapeutics (NASDAQ:CCCC) Stock Price Down 6.7%C4 Therapeutics (NASDAQ:CCCC) Stock Price Down 6.7%
americanbankingnews.com - March 26 at 1:50 PM
C4 Therapeutics, Inc.s Lock-Up Period To End  on March 31st (NASDAQ:CCCC)C4 Therapeutics, Inc.'s Lock-Up Period To End on March 31st (NASDAQ:CCCC)
americanbankingnews.com - March 24 at 1:30 AM
C4 Therapeutics (NASDAQ:CCCC) Stock Price Up 6.1%C4 Therapeutics (NASDAQ:CCCC) Stock Price Up 6.1%
americanbankingnews.com - March 22 at 1:14 PM
C4 Therapeutics Reports Recent Business Highlights and Full Year 2020 Financial ResultsC4 Therapeutics Reports Recent Business Highlights and Full Year 2020 Financial Results
finance.yahoo.com - March 11 at 9:00 PM
C4 Therapeutics to Present on the Discovery and Preclinical Development of CFT7455, a MonoDAC™ Degrader Targeting IKZF1/3, at the American Association for Cancer Research (AACR) Annual MeetingC4 Therapeutics to Present on the Discovery and Preclinical Development of CFT7455, a MonoDAC™ Degrader Targeting IKZF1/3, at the American Association for Cancer Research (AACR) Annual Meeting
finance.yahoo.com - March 10 at 6:05 PM
How Much Of C4 Therapeutics, Inc. (NASDAQ:CCCC) Do Insiders Own?How Much Of C4 Therapeutics, Inc. (NASDAQ:CCCC) Do Insiders Own?
finance.yahoo.com - March 3 at 8:11 AM
C4 Therapeutics to Participate in Upcoming March Investor ConferencesC4 Therapeutics to Participate in Upcoming March Investor Conferences
finance.yahoo.com - February 24 at 9:43 AM
C4 Therapeutics to Participate in BMO BioPharma Spotlight SeriesC4 Therapeutics to Participate in BMO BioPharma Spotlight Series
finance.yahoo.com - February 11 at 10:05 AM
C4 Therapeutics Announces FDA Clearance of Investigational New Drug Application for CFT7455, an Orally Bioavailable MonoDAC for Hematologic MalignanciesC4 Therapeutics Announces FDA Clearance of Investigational New Drug Application for CFT7455, an Orally Bioavailable MonoDAC for Hematologic Malignancies
finance.yahoo.com - January 19 at 3:34 PM
C4 Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare ConferenceC4 Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 7 at 11:26 AM
C4 Therapeutics Announces Key 2021 Milestones to Support Progress Toward Goal of Four Clinical-Stage Programs by Year-End 2022C4 Therapeutics Announces Key 2021 Milestones to Support Progress Toward Goal of Four Clinical-Stage Programs by Year-End 2022
finance.yahoo.com - January 6 at 10:11 AM
C4 Therapeutics Reaches Analyst Target PriceC4 Therapeutics Reaches Analyst Target Price
nasdaq.com - December 24 at 1:21 PM
C4 Therapeutics to be Added to the Russell 2000® and Russell 3000® IndexesC4 Therapeutics to be Added to the Russell 2000® and Russell 3000® Indexes
finance.yahoo.com - December 17 at 11:09 AM
C4 Therapeutics to Present at the Evercore ISI 3rd Annual HealthCONxC4 Therapeutics to Present at the Evercore ISI 3rd Annual HealthCONx
finance.yahoo.com - November 25 at 12:03 PM
C4 Therapeutics to Present at the Jefferies Virtual London Healthcare ConferenceC4 Therapeutics to Present at the Jefferies Virtual London Healthcare Conference
finance.yahoo.com - November 13 at 8:06 AM
C4 Therapeutics Reports Business Highlights and Third Quarter 2020 Financial ResultsC4 Therapeutics Reports Business Highlights and Third Quarter 2020 Financial Results
finance.yahoo.com - November 12 at 5:05 PM
C4 Therapeutics, Inc. Common Stock (CCCC)C4 Therapeutics, Inc. Common Stock (CCCC)
nasdaq.com - October 23 at 11:36 PM
News for C4 Therapeutics Inc Registered ShsNews for C4 Therapeutics Inc Registered Shs
markets.businessinsider.com - October 15 at 11:04 PM
This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.